A Step Closer to Personalised Medicine for Liver Fibrosis

Article   Jun 02, 2017 | By Anna MacDonald, Editor for Technology Networks

 
A Step Closer to Personalised Medicine for Liver Fibrosis

Anna Macdonald

Science Writer

 
 
 

RELATED ARTICLES

How We Tackle Antibiotic Resistance Now

Article

The fight against antibiotic resistance is real and is something we all have a responsibility in tackling. In fact, antibiotic resistance kills an estimated 700,000 people each year and has fuelled the re-emergence of illnesses that had become a rarity in many parts of the world.

READ MORE

Liquid Biopsies Coming of Age

Article

Based on the analysis of cells, genes, and chemical signals in body fluids, liquid biopsies provide timely, actionable information on disease states while eliminating the high cost and risks of tissue biopsies. Gene amplification through polymerase chain reaction and related techniques offer these benefits with the added advantage of amplifying low-abundance species. This article looks at the state of the art in PCR-based liquid biopsies, including a discussion of the technique's limitations.

READ MORE

The Importance of Aflatoxin Discrimination in Food Testing

Article

Aflatoxins have been an issue in food and feed since the 1970’s, but the first global effort to regulate them took place in 2003. Aflatoxin B1 is by far the most prevalent and potent sub-type. Accordingly, maximum levels for B1 are set lower than total aflatoxin levels which highlights the need to test these two measures independently.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE